HomeM&M › Filing
🔔 Get instant alerts when M&M files quarterly results on BSE Start free trial →

This is further to our letter dated 13th November 2025, wherein we had given an advance intimation of the M&M Analyst Meeting scheduled to be held today i.e. Thursday, 13th November 2025 ....

Filed: 13 Nov 2025, 00:00 IST Exchange: BSE Category: General Update — Investor/Analyst Meet
Presentation at Mahindra & Mahindra Analyst Meeting on 13-Nov-2025. - Discussed life insurance opportunity with Manulife partnership. - Plan to invest ~INR 250 Cr/year for first 5 years. - Targeting #1 life insurer in rural and semi-urban India. - Emphasis on protection products and digital-enabled ecosystem. - Mahindra Finance distribution with 1,345+ branches and 25 lakh+ customers. - Expected valuation INR 18,000-30,000 Cr in 10 years. - Strategy focused on meaningful potential and market-leading returns.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 M&M — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add M&M to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Mahindra Mahindra Ltd

Important. The summary above is generated automatically from Mahindra Mahindra Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.